The presence of VPAC1 and VPAC2, in addition to PAC1 receptors within TG neurons and glia, suggests all three receptor subtypes play important roles in multiple cell types and represent promising targets for developing migraine and headache disorder treatments. This evidence concerns the gene VIPR1 and migraine disorder.